Axelrod Research

Archives
Log in
Subscribe
August 22, 2026

Axelrod Research — The Week: Proof, Not Personnel Headlines, Left LMT the Sole Buy

The week split cleanly between evidence that can be underwritten and headlines that cannot. Lockheed Martin remains the book’s sole BUY because demand is quantified and filed operating capacity is visible; a fresh batch of executive-move and transaction claims produced no primary confirmation, no financial bridge and therefore no new long call. [1][2][3]

The other real conclusion was valuation discipline: Merck’s bridge strengthened, Exxon’s cash generation improved and Alphabet’s AI demand stayed formidable, but none offered a better entry by Friday, 21 August 2026. [4][5][6]

The through-line: LMT is still the exception

LMT — BUY. Lockheed closed at $563.57 on 21 August 2026, below the $600 entry ceiling. The demand case is a $58.6bn Patriot contract ceiling through roughly 2032, including a reported $53.86bn firm-fixed-price modification; Q2’26 diluted EPS was $7.94 for the quarter ended 28 June 2026, operating cash flow was $3.455bn for the six months ended 28 June 2026, and cash was $3.791bn as of 28 June 2026. [1][2][7]

That is unusually visible demand, not guaranteed profit. A ceiling is not booked revenue, and firm-fixed-price terms leave Lockheed carrying the risk that rocket motors, seekers, labour and factory capacity cost more than planned. The trigger is Q3’26: Patriot value entering backlog while Missiles & Fire Control margin holds would confirm the BUY; two consecutive quarters of ramp-driven margin compression would kill it. Horizon: 18–36 months. [1][2]

The book

BUY

LMT — BUY. What changed: nothing material; Friday’s $563.57 close as of 21 August 2026 improved the entry versus the $589.15 close as of 19 August 2026 without weakening the contract thesis. Trigger: Q3’26 backlog conversion with stable Missiles & Fire Control margin. Horizon: 18–36 months. [1][2][7]

HOLD

GOOGL — HOLD. What changed: price, not evidence—GOOGL closed at $344.82 on 21 August 2026; Q2’26 operating cash flow of $39.069bn still failed to cover $44.924bn of Q2’26 capex, although TTM free cash flow remained approximately $53.3bn as of Q2’26 and Cloud grew about 82% year over year in Q2’26. Trigger: positive quarterly free cash flow with no further increase to the $195bn–$205bn FY26 capex guide; a second negative-free-cash-flow quarter without commensurate Cloud growth kills the call. Horizon: 6–9 months. [6][7]

MRK — HOLD. What changed: this is the week’s one changed call—ACCUMULATE below $125 as of 21 July 2026 became HOLD after MRK closed at $135.97 on 17 August 2026 and then $152.55 on 21 August 2026, even as Q2’26 sales rose 5% year over year to $16.6bn, KEYTRUDA/QLEX rose 5% to $8.4bn, and WINREVAIR rose 75% to $588m. Trigger: Q3’26 KEYTRUDA/WINREVAIR growth plus early LIPFENDRA access data; weak uptake or a return to $125 changes the decision in opposite directions. Horizon: 6–12 months. [4][7]

AMD — HOLD. What changed: AMD closed at $473.25 on 21 August 2026, still above the $460 accumulation line; the Anthropic agreement remains “up to” $5bn of equity investment and “up to” 2 GW of MI450 deployments, with the first-gigawatt target beginning in H1 2027. Trigger: a firm volume commitment and an intact H1’27 delivery schedule; sequentially flat or falling data-centre revenue without quantified conversion kills the thesis. Horizon: 12–18 months. [8][9]

XOM — HOLD. What changed: Q2’26 earnings of $14.5bn, operating cash flow of $23.6bn and free cash flow of $17.2bn validated execution, but the $165.11 close on 21 August 2026 still embeds limited room for oil-price normalisation. Trigger: ACCUMULATE below $150 only if Permian output remains at or above the Q2’26 record of 1.8m oil-equivalent barrels per day and free cash flow continues covering distributions; failure to cover them after crude normalises kills the call. Horizon: 6–12 months. [5][7]

META — HOLD. What changed: nothing—reported founder participation in a football-club consortium was not a Meta transaction; META closed at $549.90 on 21 August 2026. Trigger: a Meta filing showing corporate capital at risk. Horizon: until the next filing or earnings print. [7][10]

AMZN — HOLD. What changed: nothing—a founder-linked consortium and reported US$6bn club valuation did not establish an Amazon commitment; AMZN closed at $258.63 on 21 August 2026. Trigger: a filing showing Amazon, rather than an individual, is financially committed. Horizon: until the next filing or earnings print. [7][11]

LNC — HOLD. What changed: the reported CFO transition remained unmatched to a primary filing in the reviewed work; LNC closed at $42.15 on 21 August 2026. Trigger: an 8-K establishing the reason, terms and guidance effect. Horizon: one to two quarters. [7][12]

MASSY — HOLD. What changed: the reported 3.54-cent interim dividend, payable 25 September 2026 to holders of record 28 August 2026, remained unverified in primary materials. Trigger: the issuer notice plus interim cash-flow coverage. Horizon: through the next interim accounts. [13]

AHL — HOLD. What changed: the reported TT$0.08 interim dividend with 9 October 2026 record date and 30 October 2026 payment date remained an unverified distribution, not a thesis. Trigger: the primary notice and coverage in the next accounts. Horizon: through the next reporting period. [13]

AFS — HOLD. What changed: the reported J$0.10 dividend with 1 September 2026 record date and 11 September 2026 payment date remained unconfirmed. Trigger: JSE confirmation plus evidence that cash generation and credit costs support it. Horizon: through the next reporting period. [14]

UCL — HOLD. What changed: the reported TT$0.16 interim dividend with 1 September 2026 record date and 22 September 2026 payment date remained unverified. Trigger: the primary notice and next margin print. Horizon: through the next reporting period. [13]

QWI — HOLD. What changed: reported NAV of J$1.46 per share as of 7 August 2026 still lacked a verified executable price, so no discount could be underwritten. Trigger: fresh NAV and a market quote showing a sufficient discount. Horizon: until the next NAV publication. [15]

VMIL — HOLD. What changed: the reported COO resignation effective 5 August 2026 remained governance news without demonstrated operating damage. Trigger: a primary notice plus evidence of strategic or financial disruption. Horizon: one to two quarters. [16]

AVOID

INTC — AVOID. What changed: the alleged raise remained unsupported, while INTC fell from $102.50 on 14 August 2026 to $90.07 on 21 August 2026; price weakness does not validate a claimed $15bn raise allegedly upsized to $20bn. Trigger: a registration statement that supplies proceeds, offer price, share count and use of funds; attractive verified economics could flip the call. Horizon: event-driven, until filed terms exist. [7][17]

TJH — TRIM. What changed: nothing that resolves the valuation—Q2’26 profit was reported up 38% year over year, but the J$13 reference as of approximately 10 August 2026 still lacked a current verified quote, cash-flow reconciliation and dividend-coverage proof. Trigger: filed June 2026 cash conversion, Phase 1C traffic and distributions covered after maintenance capex and debt service; deterioration in any of the three confirms the trim. Horizon: 6–18 months. [18]

DB — AVOID. What changed: reported commodity hires and a strategic rebuild remained unsupported by a Deutsche Bank release; DB closed at $37.82 on 21 August 2026. Trigger: primary confirmation plus a quantified revenue, cost and capital bridge. Horizon: until the next results or strategy update. [3][7]

BCS — AVOID. What changed: reported investment-bank co-CEO appointments remained unverified; BCS closed at $26.83 on 21 August 2026. Trigger: a Barclays release or regulatory filing establishing timing, responsibilities and financial relevance. Horizon: until the next results or confirmed appointment. [7][19]

AON — AVOID. What changed: the claimed immediate CFO exit and interim appointment lacked a retrieved company release or SEC filing; AON closed at $355.11 on 21 August 2026. Trigger: an 8-K explaining the transition, advisory terms and any guidance effect. Horizon: one to two quarters. [7][20]

GEHC — AVOID. What changed: the reported CFO appointment effective 14 September 2026 remained unverified; GEHC closed at $74.82 on 21 August 2026. Trigger: an 8-K or company release confirming the appointment and transition terms. Horizon: through the appointment and next results. [7][21]

MS — AVOID. What changed: reported loss of at least two commodity-sales executives was unnamed-source reporting without identified employees or demonstrated earnings effect; MS closed at $214.20 on 21 August 2026. Trigger: primary confirmation plus evidence that client revenue or retention is affected. Horizon: one to two quarters. [7][22]

GS — AVOID. What changed: former-employer biographies were not corroborated and are not a Goldman corporate catalyst; GS closed at $1,039.28 on 21 August 2026. Trigger: a company filing establishing an actual financial or franchise effect. Horizon: until the next results. [7][23]

BAC — AVOID. What changed: a former employee’s reported move did not establish a Bank of America catalyst; BAC closed at $61.69 on 21 August 2026. Trigger: evidence of material client, revenue or leadership impact. Horizon: until the next results. [7][24]

MQBKY — AVOID. What changed: the reported €1bn sale of Polish network assets remained unmatched to a Macquarie primary release; the US ADR closed at $178.57 on 21 August 2026. Trigger: primary transaction terms and a disclosed gain, capital return or earnings effect. Horizon: through transaction confirmation or the next results. [7][25]

CR — AVOID. What changed: an executive biography supplied no current Crane catalyst; CR closed at $208.41 on 21 August 2026. Trigger: a filing that changes earnings, capital allocation or guidance. Horizon: until the next results. [7][26]

IEX — AVOID. What changed: executive-history context supplied no current IDEX catalyst; IEX closed at $234.39 on 21 August 2026. Trigger: a filing that changes earnings, guidance or capital allocation. Horizon: until the next results. [7][27]

XYL — AVOID. What changed: a former CFO’s reported move was not a Xylem trade thesis; XYL closed at $113.42 on 21 August 2026. Trigger: primary disclosure of material transition costs or strategy change. Horizon: until the next results. [7][28]

WBA — AVOID. What changed: the reviewed work flagged stale-ticker and ownership risk, and no 21 August 2026 US daily bar was available. Trigger: verified current listing and ownership status before any security-level call can be reconsidered. Horizon: indefinite until status is resolved. [29]

EPLY — AVOID. What changed: the reported 7.25% preference-share redemption and delisting at maturity on 17 August 2026 was an instrument exit, not a reason to buy the ordinary equity. Trigger: primary confirmation of redemption completion and any balance-sheet effect. Horizon: through the next filing. [30]

Changed my mind

Only MRK moved: the post-Keytruda bridge became more credible in Q2’26, but the share price moved far beyond the prior $125 accumulation ceiling, so better evidence produced a HOLD rather than a chase. Every other call held; that is a position on evidence quality, not an absence of work. [4][7]

What I’m watching next week: MASSY’s 28 August 2026 record date; any Intel financing document; and primary filings confirming—or disproving—the DB, BCS, AON and GEHC personnel claims. [3][13][17][19][20][21]

Sources

  1. LMT Q2’26 10-Q
  2. Lockheed investor relations
  3. Deutsche Bank reports
  4. Merck Q2’26 results
  5. Exxon Q2’26 results
  6. Alphabet Q2’26 10-Q
  7. Massive daily bars
  8. AMD–Anthropic release
  9. AMD Q1 FY26 10-Q
  10. Meta SEC filings
  11. Amazon SEC filings
  12. Lincoln SEC filings
  13. TTSE disclosures
  14. AFS issuer page
  15. QWI issuer page
  16. VMIL issuer page
  17. Intel SEC filings
  18. TJH issuer page
  19. Barclays reports
  20. Aon SEC filings
  21. GEHC SEC filings
  22. Morgan Stanley filings
  23. Goldman Sachs filings
  24. Bank of America filings
  25. Macquarie investors
  26. Crane SEC filings
  27. IDEX SEC filings
  28. Xylem SEC filings
  29. Walgreens investor relations
  30. Eppley issuer page

Independent equity analysis, for information only, not investment advice.

Don't miss what's next. Subscribe to Axelrod Research:
← Newer Axelrod Research — MRNA: Phase 2b Evidence Does Not Justify Chasing $145 Older → Axelrod Research — XOM: Better Cash Flow Does Not Justify Chasing $166
Powered by Buttondown, the easiest way to start and grow your newsletter.